Neuroblasztóma: vizsgálatok itt: Norvégia

5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.

• 2. fázisTaking people
  177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk Neuroblastoma

  Where

  Bergen, Oslo

  Életkor

  18 hónap to 64 év

  People

  24 worldwide

  Run by

  Jakob Stenman

  See details and how to joinNCT04903899 · EU 2023-503684-42-00
• 1/2. fázisTaking people
  A phase 1B of crizotinib either in combination or as single agent in pediatric patients with ALK, ROS1 or MET positive malignancies

  Where

  Trondheim

  Életkor

  Up to 64 év

  People

  72 worldwide

  Run by

  Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

  See details and how to join2023-504880-18-00 · EU 2023-504880-18-00
• 1/2. fázisTaking people
  A Multi-Arm, Platform Trial For Relapsed Neuroblastoma

  Where

  Oslo

  Életkor

  1 év to 64 év

  People

  160 worldwide

  Run by

  University of Birmingham

  See details and how to joinNCT07334301 · EU 2024-516115-24-00
• No phaseTaking people
  SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours

  Where

  Oslo

  People

  600 worldwide

  Run by

  Institut Curie

  See details and how to joinNCT05192980
• 3. fázisTaking people
  High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

  Where

  Bergen, Oslo, Tromsø, Trondheim

  Életkor

  Up to 21 év

  People

  800 worldwide

  Run by

  Gustave Roussy, Cancer Campus, Grand Paris

  See details and how to joinNCT04221035 · EU 2024-514917-36-00